M&B Engineering s IPO saw strong demand, fully subscribed by Day 2 with an overall subscription of 110%. Retail investors showed significant interest, subscribing 4.18 times their quota. The IPO price is set at Rs 366–385 per share, with proceeds aimed at capital expenditure and debt repayment. Brokerages are positive, citing the company s strong fundamentals and growth potential.

The Indian markets may face negative sentiment due to potential US tariffs. Manishi Raychaudhuri suggests caution, citing uncertainty around exemptions for pharmaceuticals and electronics. The impact could be significant on auto, industrial components, pharmaceuticals, and garments. Ongoing trade talks between India and the US add to the fluid situation. Details about the tariff arrangement are still awaited.

The Fed held interest rates steady, offering no clarity on a September cut, as markets recalibrate expectations.

President Trump announced a 25% tariff on Indian goods, impacting sectors like textiles and pharmaceuticals. Sensex and Nifty initially fell but recovered. Experts believe the tariff is temporary, part of ongoing trade negotiations. A US delegation will visit India in August. Investors are advised to buy the dip, focusing on domestic consumption themes.

Punjab National Bank s shares dipped 4% following a 48% YoY drop in net profit for Q1 2025, reporting Rs 1,675 crore against last year s Rs 3,251.5 crore, impacted by a significant tax expense. While total income rose 15.7%, NII saw marginal growth. Asset quality improved with reduced GNPA and NNPA.

Adrian Mowat suggests Indian markets can quickly absorb a 25% tariff impact, though it might weaken the rupee and limit the RBI s flexibility. He highlights the geopolitical motivations behind potential US penalties on India and China s oil imports from Russia. This situation could negatively affect foreign investment inflows into India due to a less favorable risk-reward scenario.

Following the release of June quarter results, eight smallcap stocks have surged, with gains ranging from 10% to 50%. This rally is fueled by robust revenue and profit growth, reflecting increased demand and improved operational efficiency. While FIIs have reduced holdings in most of these companies, mutual funds have largely increased or maintained their stakes, indicating a bullish outlook.

As global powers establish clear digital asset regulations, India must act decisively. With strong Web3 talent and startup growth, the country stands to lead in blockchain innovation. However, a lack of structured regulation could risk talent and capital outflow. Adopting global best practices is key to India’s Web3 leadership.

Indian pharma stocks fell up to 3% after U.S. President Trump announced a 25% tariff on Indian imports over its trade with Russia. Concerns rose about potential inclusion of generic drugs in the tariff list. Analysts expect strategic shifts by exporters and a cautious, range-bound market reaction.